Overview
- 12 inspections across 11 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-05-30.
At a glance
Inspections
12
Sites
11
Observations
0
Career since
Oct 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Andelyn Biosciences, Inc. | 30 May 2025 | Biologics | On file |
| Ferring Production Inc. | 7 Mar 2025 | Biologics | On file |
| GSK Vaccines GmbH | 12 Nov 2024 | Biologics | On file |
| Ten23 Health Valais AG | 28 Feb 2024 | Human Drugs | On file |
| F. Hoffmann-La Roche AG | 16 Feb 2024 | Human Drugs | On file |
Sites inspected
Andelyn Biosciences, Inc.Columbus, United States1 insp.
Ferring Production Inc.Parsippany, United States1 insp.
GSK Vaccines GmbHMarburg, Germany1 insp.
Ten23 Health Valais AGVisp, Switzerland1 insp.
F. Hoffmann-La Roche AGBasel Town, Switzerland1 insp.
Co-investigators
Investigators who share inspections with this person.
Thuy T Nguyen4 shared
Hector A Carrero2 shared
Susan S Butler1 shared
Shen Lin1 shared
Jacob L Bitterman1 shared
Phillip C Thai1 shared
Zhili Xu1 shared
Jogy George1 shared
Massoud Motamed1 shared
Bingchen Du1 shared
Full investigator report
Get the verbatim findings behind Holly Brevig's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site